Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02EVT
|
|||
| Former ID |
DIB001029
|
|||
| Drug Name |
SAR-152954
|
|||
| Synonyms |
Histamine H3 antagonist (sleep disorder), Sanofi-aventis
Click to Show/Hide
|
|||
| Indication | Sleep-wake disorder [ICD-11: 7A00-7B2Z; ICD-10: G47] | Discontinued in Phase 1 | [1] | |
| Company |
Sanofi
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Antagonist | [2] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033674) | |||
| REF 2 | Clinical pipeline report, company report or official report of Sanofi. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.